Ocean Biomedical, Inc.
FRC CoverageOcean Biomedical, Inc.
FRC CoverageYour view on OCEA
Overview
What the company does, where it operates, and who runs it.
*Ocean Biomedical, Inc. has paid FRC a fee for research coverage and distribution of reports.
About Ocean Biomedical, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Chirinjeev Kathuria
- Headquarters
- Room 325, 55 Claverick Street, Providence, RI, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Chirinjeev Kathuria
- Headquarters
- Room 325, 55 Claverick Street, Providence, RI, US
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.
Infographics
Visual summary of the business at a glance.
Research Reports
FRC analyst coverage and recommendations.
Past Reports
Historical coverage archive.
Analyst Notes
Ongoing commentary and updates from FRC analysts.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.